Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Mancia, G.
Right arrow Articles by Grassi, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mancia, G.
Right arrow Articles by Grassi, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Blood pressure reduction as part of the multifactorial approach to treatment of cardiovascular disease

G. Mancia* and G. Grassi

Clinica Medica e Università di Milano-Bicocca, Ospedale San Gerardo, Monza, Milano, Italy

* Correspondence: Professor Giuseppe Mancia, Clinica Medica, Università di Milano-Bicocca, Ospedale San Gerardo, Via Donizetti 106, 20052 Monza, Milan, Italy.

Abstract

Antihypertensive drud treatment has been unequivocally shown to exert favourable cardiovascular effects by reducing the incidence of (and delaying the occurrence of) major complications of hypertension, i.e. stroke, coronary atherosclerosis, congestive heart failure and renal insufficiency. Evidence has also been provided that the benefits of antihypertensive treatment (1) can be observed not only in diastolic or systo-diastolic hypertensive states but also in isolated systolic hypertensions and (2) are not related to a specific antihypertensive drug regimen but rather to the blood pressure lowering per se. The latter statement has been confirmed by the results of recently published clinical trials, demonstrating the ability of ACE inhibitors and calcium antagonists to exert cardioprotective properties similar to those induced by conventional antihypertensive drug treatment. Recent clinical trials have also shown that further advantages in patient protection can be achieved by lowering diastolic blood pressure values to well below 90 mmHg, particularly when high blood pressure is accompanied by diabetes and renal insufficiency.

Key Words: Antihypertensive treatment • clinical trials • management guidelines

References

  1. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exper Hypertens. 1993;15:967–978
  2. Herbert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence of drug therapy of mild to moderate hypertension and decreased risk of CHD. Arch Intern Med. 1993;153:578–581[Abstract/Free Full Text]
  3. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham Study. Am J Cardiol. 1971;27:335–346[CrossRef][Web of Science][Medline]
  4. Rutan GH, Kuller LH, Neaton JD, et al. Mortality associated with diastolic hypertension and isolated systolic hypetension among men screened for the Multiple Risk Factor Intervention Trial. Circulation. 1988;77:504–514[Abstract/Free Full Text]
  5. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985;i:1349–1354
  6. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. J Am Med Assoc. 1991;265:3255–3264[Abstract/Free Full Text]
  7. Staessen JA, Fagard R, Thijs L, et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757–764[CrossRef][Web of Science][Medline]
  8. Lin L, Wang WG, Gong L, et alSystolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older patients with isolated systolic hypertension. J Hypertens. 1998;16:1823–1829[CrossRef][Web of Science][Medline]
  9. Burt VL, Culter JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the health examination surveys 1960 to 1991. Hypertension. 1995;26:305–316
  10. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol and stroke in Eastern Asia. Lancet. 1998;352:1801–1807[CrossRef][Web of Science][Medline]
  11. Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens. 1996;14:1237–1245[Web of Science][Medline]
  12. The Heart Outcomes Prevention Evaluation Study Investigators. Effect of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145–153[Abstract/Free Full Text]
  13. Hansson L, Lindholm LH, Ekborn T, et al. Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity in the Swedish Trial in Old Patients with Hypertension-2 Study. Lancet. 1999;354:1751–1756[CrossRef][Web of Science][Medline]
  14. Hansson L, Hedner T, Lund-Johansen P, et al. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension : the Nordic Diltiazem (NORDIL) Study. Lancet. 2000;356:359–365[CrossRef][Web of Science][Medline]
  15. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or a diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000;356:366–372[CrossRef][Web of Science][Medline]
  16. Guidelines Subcommittee. 1999 World Health Organization/International Society of Hypertension Guidelines for the management of hypertension. J Hypertens. 1999;17:151–183[Web of Science][Medline]
  17. Mancia G, Grassi G. Antihypertensive treatment: past, present and future. J Hypertens. 1998;16(Suppl 1):51–57[CrossRef][Web of Science][Medline]
  18. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet. 1998;351:1755–1762[CrossRef][Web of Science][Medline]
  19. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease, part 2. Short-term reduction in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;325:827–838
  20. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J. 1998;317:713–720[Abstract/Free Full Text]
  21. Hypertension, Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in ‘mild’ hypertension: results of the Hypertension, Detection and Follow-up Program. N Engl J Med. 1982;307:976–980[Abstract]
  22. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997. p. 2413–2446
  23. Kaplan NM. Multiple risk factors for coronary heart disease in patients with hypertension. J Hypertens. 1995;13(Suppl 2):S1–S5
  24. Zanchetti A. The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. Clin Exper Hypertens. 1992;A14:307–331
  25. Zanchetti A. Trials investigating the antiatherosclerotic effects of antihypertensive drugs. J Hypertens. 1996;14(Suppl 2):S77–S81[CrossRef]
  26. Jennings G, Wong J. Regression of left ventricular hypertrophy in hypertension: changing patterns with successive meta-analyses. J Hypertens. 1998;16(Suppl 6):S29–S34

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Mancia, G.
Right arrow Articles by Grassi, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mancia, G.
Right arrow Articles by Grassi, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?